Table 5.
Adherence across visits.
| # | Quality measure | Never | Sometimes | Always |
|---|---|---|---|---|
| Measure 1 (visits) | ||||
| 1 | All type, all freq | 35.0 | 41.0 | 24.0 |
| 1a | All type, sum freq | 30.0 | 33.0 | 37.0 |
| 1b | Sz type | 21.0 | 26.0 | 53.0 |
| 1c | Sz type only | 75.0 | 22.0 | 3.0 |
| 1d | Sz type, some freq | 86.0 | 14.0 | 0.0 |
| 1e | Sz freq | 6.0 | 23.0 | 71.0 |
| Measure 2 (visits) | ||||
| 2 | Etio or syndr | 34.0 | 23.0 | 43.0 |
| 2a | Etio | 62.0 | 14.0 | 24.0 |
| 2b | Syndr | 71.0 | 11.0 | 18.0 |
| Measure 3 (visits) | ||||
| 3 | EEG | 12.0 | 29.0 | 59.0 |
| Measure 4 (visits) | ||||
| 4 | Imaging | 40.6 | 27.5 | 31.9 |
| 4a | MRI | 40.2 | 27.2 | 32.6 |
| 4b | Imaging in all subs | 40.2 | 27.2 | 32.6 |
| 4c | Imaging in focal epi | 40.5 | 21.6 | 27.8 |
| Measure 5 (visits) | ||||
| 5 | ASD side effects | 18.0 | 27.0 | 55.1 |
| 5a | Starting new ASD | 0.0 | 0.0 | 100.0a |
Measures 6–8were excluded because they are not rated on a per-visit basis. Proportion of times patients with >1 visit never met the adherence criteria, sometimes (but not always) met the adherence criteria, and always met the adherence criteria.
a
Note: measure 5a included only six subjects.